loading...

Screener and Opioid Assessment for Patients with Pain – 12-item version (SOAPP-12)

Finckerman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Hong Chang; Dong J; Butler SF

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Published in 2017
  • Derived from the SOAPP-Revised (R) version developped in 2008
Authors

Finckerman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Hong Chang; Dong J; Butler SF

Copyright
SOAPP-12 © Inflexxion, an IBH Company, 2019
Objective
To predict aberrant medication-related behaviors among chronic pain patients considered for long-term opioid therapy
Therapeutic area
  • Mental Disorders
  • Chemically-Induced Disorders
Therapeutic indication

Opioid-Related Disorders

This instrument should be used only with chronic pain patients being considered for long-term opioid therapy and not with all patients with chronic pain
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Finkelman MD, et al. Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study. Pain Med. 2017 Jul 1;18(7):1292-1302 (Full text article)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Finckerman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Hong Chang; Dong J; Butler SF

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us